Concepedia

Publication | Open Access

Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line <i>Helicobacter pylori</i> treatment: a randomized trial

DOIFull Paper Access

99

Citations

25

References

2003

Year

E.C. Nista, Marcello Candelli, Filippo Cremonini, I.A. Cazzato, S. Di, Maurizio Gabrielli, Lory Santarelli, Maria Assunta Zocco, Veronica Ojetti, E. Carloni,
Alimentary Pharmacology & Therapeutics

Abstract

Ten-day levofloxacin-based therapies are better than standard quadruple regimens as second-line option for H. pylori eradication.

References

YearCitations

Page 1